FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$3.72B
1-Year Est. Return
129.71%
This Fund
S&P 500
1 Year Est. Return
+129.71%
AUM
$3.34B
AUM Growth
+$837M
(+33%)
Holding
53
Top Buys
| 1 | +$23.2M | |
| 2 | +$14.5M | |
| 3 | +$13.8M | |
| 4 |
Dyne Therapeutics
DYN
|
+$13.8M |
| 5 |
Zai Lab
ZLAB
|
+$11M |
Top Sells
| 1 | +$21.1M | |
| 2 | +$20M | |
| 3 | +$12.9M | |
| 4 |
Cogent Biosciences
COGT
|
+$12.5M |
| 5 |
Travere Therapeutics
TVTX
|
+$11.5M |
Sector Composition
| 1 | Healthcare | 99.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Oric Pharmaceuticals
ORIC
$1.35B
| – | – |
-1,065,334
|
|
||
|
ORKA
52
Oruka Therapeutics
ORKA
$1.64B
| – | – |
-583,327
|
|
||
|
53
Cogent Biosciences
COGT
$6.23B
| – | – |
-1,734,601
|
|